2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
---|---|---|---|---|---|
营业收入(元) | |||||
骨科产品(元) | 232,805,608.37 | 476,087,646.10 | 231,830,216.58 | 388,448,224.35 | 178,684,098.51 |
眼科产品(元) | 451,567,565.92 | 928,214,432.86 | 480,510,395.96 | 769,875,759.19 | 355,986,154.21 |
整形美容与创面护理产品(元) | 634,499,020.40 | 1,056,860,493.91 | 484,873,005.07 | 748,138,665.13 | 328,742,766.61 |
防粘连及止血产品(元) | 69,166,023.65 | 146,486,277.16 | 90,743,633.09 | 177,170,805.60 | 84,119,323.32 |
其他产品(元) | 16,405,494.48 | 37,419,888.44 | 24,945,200.92 | 30,533,172.47 | 20,256,425.59 |
营业成本(元) | |||||
骨科产品(元) | 46,209,208.68 | 94,862,705.12 | - | 69,194,011.14 | - |
眼科产品(元) | 195,052,247.32 | 379,511,975.61 | - | 316,935,279.07 | - |
整形美容与创面护理产品(元) | 141,203,800.76 | 238,281,682.88 | - | 201,182,748.70 | - |
防粘连及止血产品(元) | 23,402,030.69 | 46,254,615.94 | - | 57,084,761.24 | - |
其他产品(元) | 8,244,181.38 | 22,490,131.33 | - | 12,118,135.71 | - |
毛利(元) | |||||
骨科产品(元) | 186,596,399.69 | 381,224,940.98 | - | 319,254,213.21 | - |
眼科产品(元) | 256,515,318.60 | 548,702,457.25 | - | 452,940,480.12 | - |
整形美容与创面护理产品(元) | 493,295,219.64 | 818,578,811.03 | - | 546,955,916.43 | - |
防粘连及止血产品(元) | 45,763,992.96 | 100,231,661.22 | - | 120,086,044.36 | - |
其他产品(元) | 8,161,313.10 | 14,929,757.11 | - | 18,415,036.76 | - |
毛利率(%) | |||||
骨科产品(%) | 80.15 | 80.07 | - | 82.19 | - |
眼科产品(%) | 56.81 | 59.11 | - | 58.83 | - |
整形美容与创面护理产品(%) | 77.75 | 77.45 | - | 73.11 | - |
防粘连及止血产品(%) | 66.17 | 68.42 | - | 67.78 | - |
其他产品(%) | 49.75 | 39.90 | - | 60.31 | - |
收入构成(%) | |||||
骨科产品(%) | 16.58 | 18.00 | 17.66 | 18.37 | 18.46 |
眼科产品(%) | 32.15 | 35.09 | 36.60 | 36.42 | 36.78 |
整形美容与创面护理产品(%) | 45.18 | 39.96 | 36.93 | 35.39 | 33.97 |
防粘连及止血产品(%) | 4.92 | 5.54 | 6.91 | 8.38 | 8.69 |
其他产品(%) | 1.17 | 1.41 | 1.90 | 1.44 | 2.09 |
毛利构成(%) | |||||
骨科产品(%) | 18.84 | 20.46 | - | 21.90 | - |
眼科产品(%) | 25.90 | 29.44 | - | 31.07 | - |
整形美容与创面护理产品(%) | 49.81 | 43.92 | - | 37.52 | - |
防粘连及止血产品(%) | 4.62 | 5.38 | - | 8.24 | - |
其他产品(%) | 0.82 | 0.80 | - | 1.26 | - |